MLEC (Moolec Science) YoY EBITDA Growth: 85.32% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MLEC Moolec Science SA MLEC
44 GF Score
Price $6.88
GF Value $84.84
Valuation Possible Value Trap
! 9 Warning Signs
View Full Analysis

What is Moolec Science YoY EBITDA Growth?

Moolec Science MLEC -2.82% 44 YoY EBITDA Growth is 85.32% as of Dec. 2025. GuruFocus rates MLEC with a GF Score™ of 44/100 and a GF Value™ of $84.84 (Possible Value Trap). The stock has 9 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Moolec Science's YoY EBITDA Growth for the quarter that ended in Dec. 2025 was 85.32%.

Moolec Science's EBITDA per Share for the six months ended in Dec. 2025 was $-10.66.

Moolec Science YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Moolec Science's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Moolec Science YoY EBITDA Growth Chart

Moolec Science Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
YoY EBITDA Growth
0.00 0.00 1,922.08 -77.20 -438.61

Moolec Science Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only 93.50 -82.94 -473.79 -324.42 85.32
MLEC
44GF Score
Moolec Science SA MLEC
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Moolec Science YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Moolec Science's YoY EBITDA Growth for the fiscal year that ended in Jun. 2025 is calculated as:

YoY EBITDA Growth (A: Jun. 2025 )
=(EBITDA per Share (A: Jun. 2025 )-EBITDA per Share (A: Jun. 2024 ))/ | EBITDA per Share (A: Jun. 2024 ) |
=(-254.459-75.149)/ | 75.149 |
=-438.61 %

Moolec Science's YoY EBITDA Growth for the quarter that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (Q: Dec. 2025 )
=(EBITDA per Share (Q: Dec. 2025 )-EBITDA per Share (Q: Dec. 2024 )) / | EBITDA per Share (Q: Dec. 2024 )) |
=(-10.657--72.59)/ | -72.59 |
=85.32 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 85.32% mean?
Moolec Science (MLEC) has a YoY EBITDA Growth of 85.32% as of Dec. 2025. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Moolec Science and its competitors.
Is Moolec Science's YoY EBITDA Growth too high?
Moolec Science's current YoY EBITDA Growth is 85.32%. Overall, Moolec Science has a GF Score™ of 44/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Moolec Science's YoY EBITDA Growth compare to CELZ and DRMA?
Moolec Science's YoY EBITDA Growth of 85.32% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Biotechnology company?
A good YoY EBITDA Growth depends on the Biotechnology industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Moolec Science and its competitors. Moolec Science's current YoY EBITDA Growth is 85.32%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Moolec Science stock overvalued right now?
Based on GuruFocus' analysis, Moolec Science (MLEC) is currently considered Possible Value Trap. The stock's GF Value™ is $84.84, compared to a current price of $6.88 — trading 91.9% below its estimated fair value. The current YoY EBITDA Growth is 85.32%. Moolec Science's overall GF Score™ is 44/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Moolec Science (MLEC), the current YoY EBITDA Growth is 85.32% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Moolec Science (MLEC) Overvalued in 2026?

Based on GuruFocus' analysis, Moolec Science stock appears to be undervalued. The current stock price of $6.88 is trading 91.9% below its estimated GF Value™ of $84.84. GuruFocus considers Moolec Science to be Possible Value Trap.

Key valuation signals for MLEC:

  • YoY EBITDA Growth: 85.32%
  • GF Value™: $84.84 vs. price of $6.88 (91.9% below fair value)
  • GF Score™: 44/100 with 9 warning signs

No single metric tells the full story. See the MLEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Moolec Science Business Description

Address c/o Ogier Global (Cayman) Limited, 89 Nexus Way, Camana Bay, Grand Cayman, CYM, KY1-9009
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline, such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's maximum revenues from operations in Argentina.
44GF Score

Get the complete analysis for MLEC

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.88
Price
$84.84
GF Value